Computational models, databases and tools for antibiotic combinations.

Brief Bioinform

Department of Respiratory Medicine, the First Hospital of Jilin University, Changchun, China.

Published: September 2022

Antibiotic combination is a promising strategy to extend the lifetime of antibiotics and thereby combat antimicrobial resistance. However, screening for new antibiotic combinations is both time-consuming and labor-intensive. In recent years, an increasing number of researchers have used computational models to predict effective antibiotic combinations. In this review, we summarized existing computational models for antibiotic combinations and discussed the limitations and challenges of these models in detail. In addition, we also collected and summarized available data resources and tools for antibiotic combinations. This study aims to help computational biologists design more accurate and interpretable computational models.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bib/bbac309DOI Listing

Publication Analysis

Top Keywords

antibiotic combinations
20
computational models
16
tools antibiotic
8
antibiotic
6
computational
5
combinations
5
models databases
4
databases tools
4
combinations antibiotic
4
antibiotic combination
4

Similar Publications

Plague, caused by , poses a public health threat not only due to sporadic outbreaks across the globe but also due to its potential as a biothreat agent. Ironically, among the seven deadliest pandemics in global history, three were caused by . Pneumonic plague, the more contagious and severe form of the disease, is difficult to contain, requiring either prophylactic antibiotic treatment or vaccination.

View Article and Find Full Text PDF

This study explores the development and characterization of spray-dried composite microparticles consisting of levofloxacin (LVX, a broad-spectrum antibiotic), and ambroxol (AMB, a mucolytic agent that has antibacterial and antibiofilm properties), for the intended application of the drug against lower respiratory tract infections (LRTIs). A range of LVX to AMB mass ratios (1:1, 1:0.5, and 1:0.

View Article and Find Full Text PDF

Biofilms are a well-known multifactorial virulence factor with a pivotal role in chronic bacterial infections. Their pathogenicity is determined by the combination of strain-specific mechanisms of virulence and the biofilm extracellular matrix (ECM) protecting the bacteria from the host immune defense and the action of antibacterials. The successful antibiofilm agents should combine antibacterial activity and good biocompatibility with the capacity to penetrate through the ECM.

View Article and Find Full Text PDF

(Gaertn) Roxb. and Retz. are significant botanicals in ancient Ayurvedic medicine.

View Article and Find Full Text PDF

The Daunomycin: Biosynthesis, Actions, and the Search for New Solutions to Enhance Production.

Microorganisms

December 2024

VUAB Pharma A.S, Nemanicka 2722, 370 01 České Budějovice, Czech Republic.

Daunorubicin (DNR) is an anthracycline antibiotic originating from soil-dwelling actinobacteria extensively used to treat malignant tumors. Over the decades, extensive attempts were made to enhance the production of anthracyclines by introducing genetic modifications and mutations in combination with media optimization, but the target production levels remain comparatively low. Developing an appropriate culture medium to maximize the yield of DNR and preventing autotoxicity for the producing organism remains a challenge.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!